严格控制高血压不仅可减少主要心血管事件也可降低微血管并发症。
Tight control of hypertension is essential to reduce not only major cardiovascular events but also microvascular complications.
主要研究点是死亡率和多因素死亡、心肌梗死或中风（主要心血管事件）发生率。
Primary end points were the rate of death and a composite of death, myocardial infarction, or stroke (major cardiovascular events).
药物治疗是减少冠心病介入术后支架内再狭窄、降低远期主要心血管事件的主要手段。
Medicine treatment plays key role in reducing the rate of restenosis and major adverse cardiac events.
主要心血管事件包括冠心病、脑血管意外和外周血管疾病史或糖尿病合并至少一项心血管疾病危险因素。
The major CV events included a history of coronary artery disease, stroke, peripheral vascular disease, or diabetes plus at least one other cardiovascular risk factor.
该试验的主要结果，如先前报告显示：在阿托伐他汀治疗组，患者中风和主要心血管事件发生率均显著降低。
The trial's main results, previously reported, showed that patients in the atorvastatin group were significantly less likely to experience both stroke and major cardiovascular events.
随访至术后6个月，观察两组主要心血管事件发生率（死亡、非致死性心梗、靶血管血运重建术、新发心功能衰竭）。
Main Adverse Cardiac Events: At 6 month follow-up, there didn't exist statistics difference in the incidence of death, non-fatal MI and TVR between two groups.
在糖尿病患者的总死亡率中80%系由主要的心血管事件引起。
Major cardiovascular events cause about 80% of the total mortality in diabetic patients.
与心血管事件相关的主要并发症仍是卒中。
The main complication associated with cardiovascular events is still stroke.
主要终点是发生任何心血管事件。
The primary endpoint will be the onset of any cardiovascular event.
主要死亡原因为心血管事件，占53.6%；其次为脑血管意外，占21.0%。
The leading cause of death was cardiovascular incidence (53.6%), and then cerebrovascular disorder (21.0%).
两组的30天主要不良心血管事件差异无统计学意义（P>0.05）。
There were no significant differences for major cardiovascular events in 30 days between two groups, P>0.05.
结论吸烟和糖尿病是原发性高血压患者发生新发心血管事件的主要可干预危险因素。
Conclusion Smoking and diabetes are the major risk factors of new onset CVD event in hypertensive patients.
主要终点为主要不良心血管事件（MACE），定义为死亡，心肌梗塞（MI），休克和靶血管血运重建（TVR）。
The primary end point used was major adverse cardiac events (MACE), defined as death, myocardial infarction (MI), stroke and target vessel revascularization (TVR).
主要终点为主要不良心血管事件（MACE），定义为死亡，心肌梗塞（MI），休克和靶血管血运重建（TVR）。
The primary end point used was major adverse cardiac events (MACE), defined as death, myocardial infarction (MI), stroke and target vessel revascularization (TVR).
应用推荐